Your browser doesn't support javascript.
loading
KRAS Inhibitor Resistance in MET-Amplified KRAS G12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms.
Suzuki, Shinichiro; Yonesaka, Kimio; Teramura, Takeshi; Takehara, Toshiyuki; Kato, Ryoji; Sakai, Hitomi; Haratani, Koji; Tanizaki, Junko; Kawakami, Hisato; Hayashi, Hidetoshi; Sakai, Kazuko; Nishio, Kazuto; Nakagawa, Kazuhiko.
Afiliación
  • Suzuki S; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Yonesaka K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan. yonesaka@med.kindai.ac.jp.
  • Teramura T; Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Takehara T; Division of Cell Biology for Regenerative Medicine, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Kato R; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Sakai H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Haratani K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Tanizaki J; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Kawakami H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Hayashi H; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
  • Sakai K; Department of Genome Biology, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nishio K; Department of Genome Biology, Institute of Advanced Clinical Medicine, Kindai University Faculty of Medicine, Osaka-Sayama, Osaka, Japan.
  • Nakagawa K; Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka-sayama, Osaka, Japan.
Clin Cancer Res ; 27(20): 5697-5707, 2021 10 15.
Article en En | MEDLINE | ID: mdl-34365406
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Pirimidinas / Transducción de Señal / Amplificación de Genes / Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Piperazinas / Piridinas / Pirimidinas / Transducción de Señal / Amplificación de Genes / Proteínas Proto-Oncogénicas p21(ras) / Carcinoma de Pulmón de Células no Pequeñas / Resistencia a Antineoplásicos / Proteínas Proto-Oncogénicas c-met / Inhibidores de Puntos de Control Inmunológico Tipo de estudio: Prognostic_studies Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article